AFM Investigation as a Key Analysis to Determine the Drug Location in Electrospun Drug Delivery Systems

被引:0
|
作者
Guadagno, Liberata [1 ]
Raimondo, Marialuigia [1 ]
Vertuccio, Luigi [2 ]
Ciardulli, Maria Camilla [3 ]
Sirignano, Marco [4 ]
Mariconda, Annaluisa [5 ]
Porta, Giovanna Della [3 ]
Longo, Raffaele [1 ]
机构
[1] Department of Industrial Engineering, University of Salerno, Via Giovanni Paolo II, Salerno, Fisciano,84084, Italy
[2] Department of Engineering, University of Campania Luigi Vanvitelli, via Roma 29, Aversa,81031, Italy
[3] Department of Medicine, Surgery and Dentistry, University of Salerno, Via S. Allende, Baronissi,84081, Italy
[4] Department of Chemistry and Biology, University of Salerno, Via Giovanni Paolo II, 132, Fisciano,84084, Italy
[5] Department of Science, University of Basilicata, Viale dell'Ateneo Lucano 10, Potenza,85100, Italy
关键词
Controlled drug delivery - Matrix algebra - Nafion membranes - Targeted drug delivery;
D O I
10.1002/masy.202400029
中图分类号
学科分类号
摘要
The current study analyzes the possibility of determining the drug location in electrospun polymeric matrices and forecasting the release kinetics of drug delivery systems. Electrospun membranes made of polycaprolactone (PCL) loaded with dacarbazine (the drug of choice for the treatment of melanoma) and with AuM1 (a promising synthetic Au-based complex recently proposed for antitumoral treatments) are successfully prepared. Atomic force microscopy (AFM) analysis is performed on various membranes, highlighting the relevance of investigating the three-dimensional topology of the membranes for understanding the release kinetic. The produced mats are similar for all membranes, but significant differences in the microscopic roughness wall between the systems loaded with AuM1 and dacarbazine are observed. For AuM1, which has a low affinity with the PCL matrix, the complex aggregates on the nanofibers’ external walls, consequently increasing the roughness and causing a high burst in the first hours of release. On the other hand, dacarbazine is successfully included in the bulk core of the PCL nanofibers. Thus, the release kinetics is diffusive and well described by the Fick model. © 2024 Wiley-VCH GmbH.
引用
收藏
相关论文
共 50 条
  • [41] Mucoadhesive electrospun nanofibers for drug delivery systems: applications of polymers and the parameters' roles
    Lizeth Perez-Gonzalez, Graciela
    Jesus Villarreal-Gomez, Luis
    Serrano-Medina, Aracely
    Jose Torres-Martinez, Erick
    Manuel Cornejo-Bravo, Jose
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 5271 - 5285
  • [42] PLA/PCL electrospun membranes of tailored fibres diameter as drug delivery systems
    Herrero-Herrero, M.
    Gómez-Tejedor, J.A.
    Vallés-Lluch, A.
    European Polymer Journal, 2018, 99 : 445 - 455
  • [43] Microstructural Distinction of Electrospun Nanofibrous Drug Delivery Systems Formulated with Different Excipients
    Kazsoki, Adrienn
    Szabo, Peter
    Domjan, Attila
    Balazs, Attila
    Bozo, Tamas
    Kellermayer, Miklos
    Farkas, Attila
    Balogh-Weiser, Diana
    Pinke, Balazs
    Darcsi, Andras
    Beni, Szabolcs
    Madarasz, Janos
    Szente, Lajos
    Zelko, Romana
    MOLECULAR PHARMACEUTICS, 2018, 15 (09) : 4214 - 4225
  • [44] A Patent Analysis on Nano Drug Delivery Systems
    Li, Dengyu
    Luo, Wen
    Yin, Shengwei
    Wang, Ying
    Zhao, Yanqing
    Zhu, Shiwei
    Yu, Junfeng
    Yang, Ping
    Zhang, Lina
    Xi, Zhuyan
    RECENT PATENTS ON NANOTECHNOLOGY, 2024,
  • [45] DRUG DELIVERY SYSTEMS
    BARRY, BW
    CHEMTECH, 1983, 13 (01) : 38 - 44
  • [46] DRUG DELIVERY SYSTEMS
    ROBINSON, DH
    MAUGER, JW
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (10): : S14 - S23
  • [47] DRUG DELIVERY SYSTEMS
    LANGER, R
    MRS BULLETIN, 1991, 16 (09) : 47 - 49
  • [48] DRUG DELIVERY SYSTEMS
    HOTTENROTT, C
    LIFE SUPPORT SYSTEMS, 1985, 3 (02): : 177 - 178
  • [49] DRUG DELIVERY SYSTEMS
    POLACK, AE
    ROBERTS, MS
    MEDICAL JOURNAL OF AUSTRALIA, 1986, 144 (06) : 311 - 314
  • [50] DRUG DELIVERY SYSTEMS
    THEEUWES, F
    PHARMACOLOGY & THERAPEUTICS, 1981, 13 (01) : 149 - 191